| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0012 | 1 |